Utilization of potentially inappropriate medication and risk of adverse drug events among older adults with chronic renal insufficiency: a population-wide cohort study

Abstract

Background The use of potentially inappropriate medication (PIM) in population of older adults may result in adverse drug events (ADE) already after short term exposure, especially when it is prescribed to patients with chronic kidney disease (CKD). In order to limit ADE in the treatment of older adults PIM lists have been constructed as a source of information for healthcare professionals. The aim of this study was to estimate the utilization of PIM and incidence of ADE in older adults (≥70 years) with CKD. Methods We conducted a retrospective population-wide cohort study including patients from Lower Austria who were 70 years or older and diagnosed with CKD in the period from 2008 to 2011. Utilization of PIM was estimated from prescriptions filled by target population. We estimated risks of hospitalization due to ADE within 30 days after incident PIM prescription and compared them to a PIM-free control group by using marginal structural models (MSM). Results We identified 11,547 patients (women: 50.6%, median age in 2008: 78 years) who fulfilled the inclusion criteria. In total 24.7 and 8.1% of all prescriptions from that period contained a medication with a substance listed in the EU (7)-PIM and AT-PIM list, respectively. Proton pump inhibitors and Ginkgo biloba were the most often prescribed PIMs in this population. 94.6 and 79.3% patients filled at least one EU(7)-PIM and AT-PIM prescription, respectively. Despite the relatively high utilization of PIM there was only a low incidence of clinically relevant ADE. No event type exceeded the threshold level of 1% in the analysis of risks of ADE after filling a prescription for PIM. Nevertheless, MSM analysis showed an increased risk for 11 drugs and reduced risk for 4 drugs. Conclusions PIM prescription was common among older adults with CKD, however, only a small number of these drugs eventually led to hospitalization due to ADE within 30 days after incident PIM was filled. In the absence of a clinically important PIM-related increase in risk, an assessment of potential ADE severity to a PIM list by using a warning score system seems prudent.

A focus on CKD reporting and inappropriate prescribing among older patients discharged from geriatric and nephrology units throughout Italy: A nationwide multicenter retrospective cross-sectional study

“…Previous studies have highlighted the common use of PIMs and renally inappropriate medications among hospitalized older patients with CKD (Tesfaye et al, 2019;Chahine, 2020;Sheikh Rezaei et al, 2021), suggesting a lack of appropriate assessments of medication regimens as kidney function deteriorates; however, no study has previously reported on differences in CKD diagnosis and PIM use among geriatric and nephrological acute care settings. The present study, performed in wards of Geriatrics and Nephrology, aims to assess 1) the prevalence of CKD under-reporting at hospital discharge; 2) the prevalence of inappropriate prescription/dosing of renally excreted drugs at hospital discharge; and 3) factors associated with higher rates of PIMs and CKD under-reporting in the overall population and specific settings.…”

Potentially inappropriate medication as a predictor of poor prognosis of COVID-19 in older adults: a South Korean nationwide cohort study

“…The 30 days exposure time window was chosen based on similar studies done on the PIM’s risk. 36 38 The cohorts were matched based on propensity scores and were followed for events of critical care services and deaths until release from isolation ( figure 1 ). This retrospective cohort study was approved by the Seoul National University Institutional Review Board (IRB No.…”

Antibiotic prescription after tooth extraction in adults: a retrospective cohort study in Austria

“…Substances are listed in different groups according to organs they affect and their chemical, pharmacological and therapeutic characteristics. In Austria each medication has an additional unique Austrian pharmaceutical registration number, which is linked to the ATC-codes [ 32 ]. Patients with antibiotic, antiphlogistic, analgesic, bisphosphate, and corticosteroid prescriptions were identified by ATC codes J01, M01, N01, M05BA and H02 and their subcodes, respectively.…”